Primary hepatic leiomyosarcoma (PHL) is an extremely rare tumor. The tumor has no specific presentations and often diagnosis is delayed until it reaches a significant size. We report the case of a 69-year-old female presented with a huge PHL. Due to size of the tumor and to be operable, the patient subjected to right portal vein embolization (PVE) and selective embolization of segment V. Four weeks after the PVE, liver resection was conducted (Segments V+ VI bisegmentectomy plus resection of IVA). The patient had an uncomplicated post-operative course, and discharged at the 8th post-operative day. Diagnosis of PHL was confirmed by histopathological and immunohistochemical examinations. The patient refused to receive adjuvant chemotherapy, and revealed evidence of recurrence six months after the operation, and finally died 12 months after the operation and 16 months after initial diagnosis. PHL is an extremely rare tumor and often in first presentation has significant size. Radical surgery with adjuvant chemotherapy is key feature for prolonged survival. 
INTRODUCTION
Liver tumors of mesenchymal origin are rare and account for approximately 1.0% of all primary hepatic tumors. 1 Angiosarcomas, leiomyosarcomas, fibrosarcomas, embryonic undifferentiated sarcomas and unspecified sarcomas are the most common types of primary mesenchymal tumors of the liver. 2 Primary hepatic leiomyosarcoma are rare tumors of the liver, and usually arise from intrahepatic vascular structures, bile ducts or ligamentum teres. [3] [4] [5] Presentations of the tumor usually are non-specific and diagnosis often is delayed until the tumor reaches a large size. Consequently, this has a negative impact on the prognosis regardless of therapeutic management. Due to the rare appearance of those tumors it is difficult to establish a standard of care and specific recommendations.
Surgery combined with chemotherapy is the standard of care. We herein report a case of primary hepatic leiomyosarcoma, treated surgically.
CASE
A 69-year-old female with a large hepatic mass had been admitted previously in another hospital where she underwent an operation. The proceeding was an open-close and the tumor was characterized as inoperable.
The patient was referred to our department for a second opinion. Her chief complaint was pain in the abdomen and a palpable abdominal mass. She had no history of liver disease hepatitis or alcohol abuse. Her past medical history and family history were unremarkable. Physical examination revealed a marked hepatomegaly extending from below the right costal margin to the stomach. Desmin, S100, CD34, CD117, WT1 and ER (Fig. 2 ).
Since final diagnosis was leiomyosarcoma the patient was advised to receive adjuvant chemotherapy. The patient refused to receive adjuvant chemotherapy, and revealed evidence of recurrence six months after the operation, and finally died 12 months after the operation and 16 months after initial diagnosis.
DISCUSSION
Leiomyosarcomas are malignant neoplasms that arise from smooth muscle. Hepatic leiomyosarcoma may arise from intrahepatic vascular structures, bile ducts or ligamentum teres. [4] [5] [6] Tumors arising from hepatic veins may hepatic epithelioid hemangioendothelioma. 12 The outcome for liver transplant in PHL varied with most of the cases developing recurrent or metastatic disease. 12 The role of adjuvant chemotherapy/chemo radiotherapy is not well defined. The rarity of the disease precludes randomized trial and all recommendations are based on personal expertise. Most of the patients receiving R0 liver resection are referred for adjuvant chemotherapy. In our case the patient had R0 liver resection and was referred to the oncology department. She was advised to receive adjuvant chemotherapy but refused repeatedly.
